The Clinical Application of the HearLAB Cortical Evoked Response System For Determining Aided Benefit And Adjustment of Hearing Aids in Children. Vanessa Salisbury, Clinical Scientist, Brighton and Sussex University Hospital Trust Dr Laura Booth, Clinical Scientist, Royal Berkshire Hospital NHS trust
50
Embed
Vanessa Salisbury, Clinical Scientist, Brighton and Sussex University Hospital Trust
The Clinical Application of the HearLAB Cortical Evoked Response System For Determining Aided Benefit And Adjustment of Hearing Aids in Children. Vanessa Salisbury, Clinical Scientist, Brighton and Sussex University Hospital Trust - PowerPoint PPT Presentation
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
The Clinical Application of the HearLAB Cortical Evoked Response System For Determining Aided Benefit And
Adjustment of Hearing Aids in Children.
Vanessa Salisbury, Clinical Scientist, Brighton and Sussex University Hospital Trust
Dr Laura Booth, Clinical Scientist, Royal Berkshire Hospital NHS trust
Child 1- verifying speech audibility with a softband BAHA
• Child 1 has a right sided cleft lip and palate and developmental delay.
• 8 weeks old – bilateral asymmetrical moderate to severe conductive hearing loss, confirmed using ABR.
• 9 weeks – fitted with softband BAHA• 9 months old – unable to obtain reliable behavioural
data due to developmental delay• Child 1 recently discovered BAHA as a new toy!
Parents finding BAHA difficult to manage.• Unable to verify benefit of BAHA
EUHA 2010, Hannover
Child 1
EUHA 2010, Hannover
Child 1 – unaided CAEP results
EUHA 2010, Hannover
Child 1 aided CAEP results
EUHA 2010, Hannover
Child 1 - outcome• Without BAHA • CAEPs present for /t/ at 65 dB• CAEP was not present for /g/ at 65 dB but present at 75 dB.
• With BAHA • CAEP present for /g/ at 65 dB
• Conclusion• The BAHA provides significant benefit by making a wider range
of speech sounds audible at average conversational level.• Parents were reassured and encouraged by results -both unaided
and aided.• Subsequent VRA behavioural assessment confirmed a bilateral
moderate upward sloping conductive hearing loss
EUHA 2010, Hannover
Child 2 - verifying speech audibility with hearing aids
• 7 weeks old- bilateral moderate to severe sloping sensorineural hearing loss confirmed using ABR
• 9 weeks – fitted with Nios Micro hearing aids using sound recover
• 8 months – reliable behavioural assessment confirmed ABR levels were accurate and stable
• Required confirmation that full range of speech sounds were audible
EUHA 2010, Hannover
Child 2
EUHA 2010, Hannover
Child 2 – Aided CAEP results
EUHA 2010, Hannover
Child 2 – outcome
• CAEP was present for /g/ and /t/ at 65 and 55 dB with hearing aids in place.
• Conclusion – Hearing aids are maintaining the audibility of speech at soft and louder levels in both mid and high frequencies.
• Child 2’s parents – ‘we’re pleased to know his hearing aids are doing their job. It’s reassuring to see that he can hear speech’.
EUHA 2010, Hannover
Child 3- verifying high frequency speech audibility with hearing aids
• 6 weeks old – confirmed bilateral mixed profound hearing loss• 8 weeks old – fitted with bilateral hearing aids• 2 years old- Bilateral grommets inserted• Behavioural results confirmed bilateral severe hearing loss• 2yrs 10 months - recently became very difficult to test reliably
although results obtained indicate hearing levels are stable.• Parents are concerned that Child 3’s speech sounds ‘flat’• Clinical need to confirm hearing aids are providing access to
speech – particularly high frequencies.
EUHA 2010, Hannover
Child 3 – aided CAEP results
EUHA 2010, Hannover
Child 3 outcome
• CAEP present for /t/ at 65dB. /m/• CAEP absent for /m/ at 65 dB.• Child 3 is able to hear high frequency speech at least
at conversational level• Parents and clinicians reassured re. hearing aid fitting.• 55 dB speech would have been useful but Child 3
became too distressed. To be completed at next appointment.
EUHA 2010, Hannover
Child 4 – verifying hearing aid prescription
• Child 4 has downs syndrome • 8 months - diagnosed with bilateral moderate mixed
hearing loss using ABR and fitted with bilateral hearing aids
• 21 months - unable to obtain any reliable behavioural information.
• Child 1 recently removing aids. • No up to date behavioural information to verify
hearing aid prescription
EUHA 2010, Hannover
Child 4 – unaided CAEP results
EUHA 2010, Hannover
Child 4 – aided CAEP results (1)
EUHA 2010, Hannover
Child 4 - outcome
• Unaided• CAEP absent using /t/ and /m/ 65 dB
• Aided 1• CAEP absent for /m/ at 65 dB and 75 dB, • Present for /t/ at 65dB
• Response seen only to high frequency stimulus with current hearing aid prescription.
• Changed hearing aid prescription to increase gain in low frequencies. • Aided 2
• CAEP present for /t/ at 65dB• CAEP absent for /m/ at 65dB
• ABR repeated and showed a deterioration in hearing thresholds particularly in low frequencies. Hearing aid prescription altered and CAEP now present for both low and high freq speech at quiet and conversation speech sounds.
EUHA 2010, Hannover
Child 4 – Aided results (2)
EUHA 2010, Hannover
Child 5- confirm speech audibility with hearing aids.
• 11 days old – whooping cough, ECMO treatment • Developmental delay• 13 months – bilateral severe to profound
sensorineural hearing loss confirmed using behavioural and ABR data, hearing aid fitted.
• 3 years old – speech and language therapist concerned that he is able to hear speech
• Need to confirm speech audibility.
EUHA 2010, Hannover
Child 5 – Aided CAEP results
EUHA 2010, Hannover
Child 5 outcome
• CAEP present for /t/ and /m/ at 65 dB with hearing aids
• A range of speech is audible at average conversational level.
• There is cortical activation to speech stimulus within the auditory cortex
• Informs speech and language therapy
EUHA 2010, Hannover
Child 6- Is speech audible?
• 3 years 9 months• Developmental delay including delayed speech
production• Recent MRI confirmed brain damage• Behavioural assessments inconsistent but indicate an
overall high frequency severe sensorineural hearing loss.
• DPOAEs present bilaterally.• Can she hear high frequency speech? • Does she need a hearing aid?
EUHA 2010, Hannover
Child 6 – Unaided CAEP results
EUHA 2010, Hannover
Child 6 – conclusion
• CAEP present to /t/ and /m/ at 65 and /t/, /g/ and /m/ at 55 dB
• High frequency speech is audible at average and quiet conversational levels.
• Parents reassured• Hearing aid not indicated• ? Implications for neurologist re. cortical activation.
EUHA 2010, Hannover
Child 7 – Auditory neuropathy spectrum disorder (ANSD)• Child 3 born 3 months premature• 5 months gestational age (g.a.) - diagnosed with Auditory
neuropathy spectrum disorder (ANSD) using ABR and CMs.• 10 months g.a.- reliable behavioural assessment shows an
asymmetrical moderate to severe hearing loss.• 10 months g.a. – Bilateral hearing aids fitted• Ongoing delayed speech development and attention
difficulties. He uses total communication.• Parents report fluctuating understanding of speech• ABR shows fluctuating response• 6 years old – A referral for consideration of cochlear
implantation has been made• Assessment of speech evoked CAEPs
EUHA 2010, Hannover
Child 7 – Aided CAEP results
EUHA 2010, Hannover
Child 7 - outcome
• CAEP present for /t/ and /g/ at 65dB• Speech is audible for low and high frequency speech
sounds at average conversational levels ……today.• Indicates potential for speech development….today.
EUHA 2010, Hannover
Are Speech evoked CAEPs useful in clinical practice?
• Methodology straightforward and fun for an experienced paediatric audiologist and the parents.
• Allow ~ 45 minute appointment• Children are awake!• ‘Real world’ stimulus.• They can complement current audiology good practice• Infants too young for behavioural assessment• ANSD• Children for whom speech and or behavioural testing is not
reliable.
EUHA 2010, Hannover
Are Speech evoked CAEPs useful in clinical practice?
• Inform parents and clinician re. child’s access to speech
• Verify changes in hearing aid prescription.• Indicate further assessment or onward referral • Cochlear implant, • ABR under general anaesthetic/sedation/ evening
home visit• Inform other health professionals e.g. speech and
language therapy, neurology.• Indicate maturity of auditory system• Auditory training
EUHA 2010, Hannover
Is the Hearlab a useful clinical tool?
• Yes!
• Automatic waveform detection makes speech evoked CAEP assessment more accessible to audiologists whatever their experience.
• Analysis is consistent across clinicians.• Speech sounds cover relevant speech range both
for frequency and intensity.• Instant results!
EUHA 2010, Hannover
Is the Hearlab a useful clinical tool?
• However….• Automatic waveform detection could restrict new applications
of infant CAEPs• Software upgrades available to reflect up to date research
• Clinicians may want a wider range of speech sounds and intensity levels.• Software updates may be available should the clinical need
arise• Portability.• Overall, It has become an invaluable addition to our clinical
toolkit.
EUHA 2010, Hannover
Thank you!
• Dr Laura Booth, Clinical Scientist, Audiology Department, Reading, U.K.
• Dr Bram Van Dun, NAL laboratories, Sydney, Australia• Dr Rob Low, Clinical Scientist, Audiology department,